Clinical Trial Update: Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer has completed. The summary notes the status as COMPLETED but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CELEBREX (Celecoxib)
• Paraplatin (Carboplatin)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED